Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Biodesix (BDSX) Accumulated Depreciation & Amortization (2019 - 2025)

Biodesix (BDSX) has disclosed Accumulated Depreciation & Amortization for 7 consecutive years, with $12.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Accumulated Depreciation & Amortization rose 37.03% year-over-year to $12.5 million, compared with a TTM value of $12.5 million through Dec 2025, up 37.03%, and an annual FY2025 reading of $12.5 million, up 37.03% over the prior year.
  • Accumulated Depreciation & Amortization was $12.5 million for Q4 2025 at Biodesix, up from $11.7 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $12.5 million in Q4 2025 and bottomed at $5.6 million in Q4 2023.
  • Average Accumulated Depreciation & Amortization over 5 years is $8.1 million, with a median of $7.3 million recorded in 2022.
  • The sharpest move saw Accumulated Depreciation & Amortization dropped 20.03% in 2023, then surged 62.76% in 2024.
  • Year by year, Accumulated Depreciation & Amortization stood at $6.7 million in 2021, then rose by 3.99% to $7.0 million in 2022, then fell by 20.03% to $5.6 million in 2023, then soared by 62.76% to $9.1 million in 2024, then surged by 37.03% to $12.5 million in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for BDSX at $12.5 million in Q4 2025, $11.7 million in Q3 2025, and $9.1 million in Q4 2024.